1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease : a phase 1/2 open-label trial
(2026) In Nature Medicine
- Contribution to journal › Article
- 2025
-
Mark
Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease : A Randomized Clinical Trial
- Contribution to journal › Article
-
Mark
STEM-PD trial protocol : a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease
- Contribution to journal › Article
- 2023
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
- Contribution to journal › Article
